All Policies Include Coronavirus Cover

Coronavirus FAQs

Questions about cover for coronavirus? Read our FAQs and find out what our policies can do for you. If you would like to contact us, please note we are currently only available 09:00 to 17:30 Monday to Friday due to reduced operational capacity. Thank you.

Prostate cancer breakthrough hailed

26 May 2015 09:33

Could a prostate cancer breakthrough be in the offing?

Could a prostate cancer breakthrough be in the offing?

A "ground-breaking" study could offer fresh hope for patients with advanced prostate cancer.

Scientists have likened the discovery to the cancer's "Rosetta stone". This is because an Anglo-American team cracked the disease's genetic code.

It means 90% of patients may be treated soon through tailor-made medications targeting particular gene faults, boosting their survival chances.

Who will it help most?

Scientists believe their results will particularly help patients who stop responding to current treatments.

They hope sufferers with so-called metastatic cancer dispersing to their vital organs and bones will be given new treatment choices.

Travelling with peace of mind

Anyone taking a holiday while living with prostate cancer should arrange travel insurance for pre-existing medical conditions.

This assures that tourists who have got or who have recently overcome severe medical conditions can enjoy the insurance they require to travel overseas safely.

What the experiments found

The scientists plotted a pioneering genetic map of DNA mutations associated with various kinds of lethal prostate cancer.

They discovered that nearly nine out of 10 males whose genes they analysed carried faults which could be potentially treated.

In addition, they found that around one in 12 men (8%) were made vulnerable to the disease by being born with specific defects in their DNA.

The researchers collected vast amounts of cancerous growths which had dispersed to the livers, lymph nodes, bones and soft tissues of 150 sufferers in the advanced stages of prostate cancer.

Iain Frame, Prostate Cancer UK's research director, called the findings "ground-breaking" and "incredibly exciting".